Dipesh Khanal

Dr. Dipesh Khanal

Faculty of Pharmacy, The University of Sydney, Sydney, Australia

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2019 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
IKIsra Khatib
Isra Khatib
DKDipesh Khanal
Dipesh Khanal
JRJuanfang Ruan
Juanfang Ruan
DCDavid Cipolla
David Cipolla
FDFrancis Dayton
Francis Dayton
HCHak-Kim Chan
Hak-Kim Chan

4 April 2018 in Nanoscale Horizons
Verified
Journal Article
Closed access
PDF file
SKSally Yunsun Kim
Sally Yunsun Kim
DKDipesh Khanal
Dipesh Khanal
PTPriyanka Tharkar
Priyanka Tharkar
BKBill Kalionis
Bill Kalionis
Wojciech ChrzanowskiWojciech Chrzanowski
Wojciech Chrzanowski
An innovative high-resolution nano-bio-spectroscopy approach to identify nanoscale differences in the structural composition of individual stem cell-derived extracellular vesicles.

10 August 2020 in Nanoscale Advances
Verified
Journal Article
Open access
PDF file
DKDipesh Khanal
Dipesh Khanal
QLQingyu Lei
Qingyu Lei
GPgabriela pinget
gabriela pinget
DCDaniel A. Cheong
Daniel A. Cheong
AGArchana Gautam
Archana Gautam
Wojciech ChrzanowskiWojciech Chrzanowski
Wojciech Chrzanowski
Protein corona determines fate and cytotoxicity of nanoparticles in biological systems.

14 May 2020 in Analytical Chemistry
Verified
Journal Article
Closed access
DKDipesh Khanal
Dipesh Khanal
JZJing Zhang
Jing Zhang
WKWei-Ren Ke
Wei-Ren Ke
MHMark M. Banaszak Holl
Mark M. Banaszak Holl
HCHak-Kim Chan
Hak-Kim Chan

11 October 2023 in International Journal of Pharmaceutics
Verified
Journal Article
Open access
YCYue Cao
Yue Cao
DKDipesh Khanal
Dipesh Khanal
JKJinhee Kim
Jinhee Kim
RCRachel Yoon Kyung Chang
Rachel Yoon Kyung Chang
ABAlex Seungyeon Byun
Alex Seungyeon Byun
HCHak-Kim Chan
Hak-Kim Chan
Bacteriophages or phages used as an alternative therapy for treating multi-drug resistant infections require formulation consideration. Current strategies to produce phage formulations involving organic solvents are based on empirical practices without a good understanding of phage stability during formulation development. In this study, we investigated the effect of common formulation organic solvents (ethanol, isopropyl alcohol, tetrahydrofuran (THF) and dimethyl sulfoxide (DMSO)) on the stability of Pseudomonas aeruginosa-specific myovirus (PEV1, PEV20) and podovirus (PEV31) phages using biological assay, transmission electron microscopy (TEM) and scattering near field optical microscopy (SNOM). The three phages were mixed with the solvents at different concentrations (25%, 50%, and 75% (v/v)) for 20 min. All phages were fully viable in the organic solvents at 25% (v/v) showing negligible titre changes. At the higher solvent concentration of 50% (v/v), the myoviruses PEV1 and PEV20 remained relatively stable (titre loss 0.4-1.3 log10), whereas the podovirus PEV31 became less stable (titre loss 0.25-3.8 log10), depending on the solvent used. Increasing the solvent level to 75% (v/v) caused increased morphological changes in TEM and decreased viability as indicated by the titre loss (0.32-7.4 log10), with DMSO being the most phage-destabilising solvent. SNOM spectra showed differences in the signal intensity and peak positions in the amide I and amide II regions, revealing altered phage proteins by the solvents. In conclusion, the choice of the solvents for phage formulation depends on both the phages and solvent types. Our results showed (1) the phages are more stable in the alcohols than DMSO and THF, and (2) the myoviruses tend to be more stable than the podovirus in the solvents. Overall, a low to moderate (25-50 % v/v) level of organic solvents (except 50% THF) can be used in formulation of the phages without a substantial titre loss.

19 June 2020 in Analytical Chemistry
Verified
Journal Article
Closed access
DKDipesh Khanal
Dipesh Khanal
IKIsra Khatib
Isra Khatib
JRJuanfang Ruan
Juanfang Ruan
DCDavid Cipolla
David Cipolla
FDFrancis Dayton
Francis Dayton
WCWojciech Chrzanowski
Wojciech Chrzanowski